Alvaro Vega-Hidalgo
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value.
Journal: Frontiers in public health
Published: October 14, 2024
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.
Journal: Applied health economics and health policy
Published: December 14, 2023
Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper.
Journal: Orphanet journal of rare diseases
Published: September 21, 2022
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain.
Journal: Frontiers in public health
Published: July 22, 2022
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: April 11, 2022
A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System.
Journal: International journal of chronic obstructive pulmonary disease
Published: February 22, 2022
Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment.
Journal: European journal of cancer care
Published: February 14, 2022
The economic burden of pulmonary arterial hypertension in Spain.
Journal: BMC pulmonary medicine
Published: October 26, 2021
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 15, 2021
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain.
Journal: Global & regional health technology assessment
Published: August 24, 2021
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.
Journal: Advances in therapy
Published: April 21, 2021
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis.
Journal: BMC health services research
Published: April 16, 2021
Last Updated: 09/26/2026